Asian Equities Analyst, Logistics & Transport, Tracking Traffic

Daniel Hellberg

Asian Equities Analyst, Logistics & Transport

Tracking Traffic

Focusing on Asian logistics, transportation, and travel companies

Equity Bottom-Up

<ul>
<li>"Pent-Up demand"? No signs of it anywhere in outbound or domestic metrics</li>
<li>Sluggish outbound demand, capacity trajectories continued to lag in November</li>
<li>YTD share performance weak, mirrors disappointing recovery in travel activity</li>
</ul>


"Pent-Up demand"? No signs of it anywhere in outbound or domestic metrics
Sluggish outbound demand, capacity trajectories continued to lag in November
YTD share performance weak, mirrors disappointing recovery in travel activity


Monthly Chinese Tourism Tracker | No "Pent-Up Demand"! | Weak YTD Returns, Too | (December 2023)

Blue Lotus China New Economy Research, Blue Lotus Research Institute

Eric Wen

Blue Lotus China New Economy Research

China growth and global non-US Internet equities

Blue Lotus Research Institute

Blue Lotus Research is a Hong Kong Type 4 Licensed investment advisory firm focusing on Chinese growth equities and global non-US Internet equities

Thematic (Sector/Industry)

<ul>
<li>TCOM/HTHT/ATAT: China Tourism - OTA platform DAU remain lackluster, weak year end travel demand (-)</li>
<li>MNSO: Korea’s top dollar store chain Daiso buys out Japanese shareholder (-)</li>
<li>9995HK：Harbour BioMed have signed an exclusive licensing agreement with Pfizer of a mesothelin (MSLN) antibody-drug conjugate (ADC) (-) </li>
</ul>


TCOM/HTHT/ATAT: China Tourism - OTA platform DAU remain lackluster, weak year end travel demand (-)
MNSO: Korea’s top dollar store chain Daiso buys out Japanese shareholder (-)
9995HK：Harbour BioMed have signed an exclusive licensing agreement with Pfizer of a mesothelin (MSLN) antibody-drug conjugate (ADC) (-) 


[Blue Lotus Daily]: TCOM/HTHT/ATAT/MNSO/9995 HK/XPEV

<ul>
<li>In early December 2022, Chinese authorities relaxed many Covid-19 restrictions</li>
<li>A year in, the recovery in Chinese tourism activity has disappointed, so far</li>
<li>Similarly, most Chinese tourism stocks have performed poorly over the last year</li>
</ul>


In early December 2022, Chinese authorities relaxed many Covid-19 restrictions
A year in, the recovery in Chinese tourism activity has disappointed, so far
Similarly, most Chinese tourism stocks have performed poorly over the last year


12 Months In, China's Tourism Recovery & Performance of China Tourism Shares Have Both Disappointed

<ul>
<li>BABA/TCOM: China Tourism - Singapore and China to establish mutual 30-day visa exemption (+)</li>
<li>NIO: NIO Auto to spin off its battery manufacturing business for financing (+)</li>
<li>HTHT/ATAT: China Tourism Update - Chinese Embassies abroad temporarily reduce visa fees (+)</li>
</ul>


BABA/TCOM: China Tourism - Singapore and China to establish mutual 30-day visa exemption (+)
NIO: NIO Auto to spin off its battery manufacturing business for financing (+)
HTHT/ATAT: China Tourism Update - Chinese Embassies abroad temporarily reduce visa fees (+)


[Blue Lotus Daily]: BABA/TCOM/NIO/HTHT/ATAT

<ul>
<li>In October, the sluggish recovery in outbound tourism demand continued</li>
<li>Outbound capacity growth also timid; but domestic recovery is mostly complete</li>
<li>As growth stock, Trip.com's disappointed; maybe it can attract value investors?</li>
</ul>


In October, the sluggish recovery in outbound tourism demand continued
Outbound capacity growth also timid; but domestic recovery is mostly complete
As growth stock, Trip.com's disappointed; maybe it can attract value investors?


Monthly Chinese Tourism Tracker | Recovery Still Sluggish | Trip.com as Value Name | (November 2023)

China

Huazhu Group Limited operates a hotel operator and franchisor. The Company provides hotel leasing, directly hotel operation, and co-development services. Huazhu Group mainly conducts businesses in China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Huazhu Group (HTHT US)

Monthly Chinese Tourism Tracker | No "Pent-Up Demand"! | Weak YTD Returns, Too | (December 2023)

November outbound data were disappointing, and even domestic travel activity metrics appeared to move in the wrong direction. Not surprisingly,...

Tracking Traffic

[Blue Lotus Daily]: TCOM/HTHT/ATAT/MNSO/9995 HK/XPEV

China's tourism OTA platform sees low user activity and weak year-end travel demand. Korea's Daiso acquires Japanese shareholder. Harbour BioMed...

Blue Lotus Research Institute

12 Months In, China's Tourism Recovery & Performance of China Tourism Shares Have Both Disappointed

A year after most of China's pandemic-related travel restrictions were eased, we look back at the recovery in Chinese tourism activity in 2023.

Tracking Traffic

[Blue Lotus Daily]: BABA/TCOM/NIO/HTHT/ATAT

China and Singapore agree to a 30-day visa exemption for tourism, NIO Auto plans to separate its battery manufacturing for funding, and Chinese...

Blue Lotus Research Institute

Monthly Chinese Tourism Tracker | Recovery Still Sluggish | Trip.com as Value Name | (November 2023)

October outbound demand increased vs September but remains below pre-pandemic levels. We've long viewed Trip.com negatively as a growth stock, but...

Tracking Traffic

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Monthly Chinese Tourism Tracker | No "Pent-Up Demand"! | Weak YTD Returns, Too | (December 2023)

November outbound data were disappointing, and even domestic travel activity metrics appeared to move in the wrong direction. Not surprisingly,...

Tracking Traffic

[Blue Lotus Daily]: TCOM/HTHT/ATAT/MNSO/9995 HK/XPEV

​China's tourism OTA platform sees low user activity and weak year-end travel demand. Korea's Daiso acquires Japanese shareholder. Harbour BioMed...

Blue Lotus Research Institute

12 Months In, China's Tourism Recovery & Performance of China Tourism Shares Have Both Disappointed

A year after most of China's pandemic-related travel restrictions were eased, we look back at the recovery in Chinese tourism activity in 2023.

Tracking Traffic

[Blue Lotus Daily]: BABA/TCOM/NIO/HTHT/ATAT

​China and Singapore agree to a 30-day visa exemption for tourism, NIO Auto plans to separate its battery manufacturing for funding, and Chinese...

Blue Lotus Research Institute

Monthly Chinese Tourism Tracker | Recovery Still Sluggish | Trip.com as Value Name | (November 2023)

October outbound demand increased vs September but remains below pre-pandemic levels. We've long viewed Trip.com negatively as a growth stock, but...

Tracking Traffic

China's tourism OTA platform sees low user activity and weak year-end travel demand. Korea's Daiso acquires Japanese shareholder. Harbour BioMed...

China and Singapore agree to a 30-day visa exemption for tourism, NIO Auto plans to separate its battery manufacturing for funding, and Chinese...